Synthetic Biologics Inc. Shares Close the Day 14.4% Higher - Daily Wrap

The company saw its shares close the day 14.4% higher than yesterday, with trading volume higher than its 30 day average.

Jun 10, 2021 by Kwhen Finance Editors

Synthetic Biologics Inc. Shares Close the Day 14.4% Higher - Daily Wrap
Synthetic Biologics Inc. (SYN) shares closed today 14.4% higher than it did at the end of yesterday. The stock is currently up 64.3% year-to-date, up 43.8% over the past 12 months, and down 99.0% over the past five years. Today, the Dow Jones Industrial Average rose 0.1%, and the S&P 500 rose 0.5%.

Trading Activity

  • Shares traded as high as $0.64 and as low as $0.53 this week.
  • Shares closed 6e+1% below its 52-week high and 2e+2% above its 52-week low.
  • Trading volume this week was 19.1% lower than the 10-day average and 18.0% higher than the 30-day average.
  • Beta, a measure of the stock’s volatility relative to the overall market stands at 0.8.

Technical Indicators

  • The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
  • MACD, a trend-following momentum indicator, indicates an upward trend.
  • The stock closed below its Bollinger band, indicating it may be oversold.

Market Comparative Performance

  • The company's share price beats the S&P 500 Index today, beats it on a 1-year basis, and lags it on a 5-year basis
  • The company's share price beats the Dow Jones Industrial Average today, beats it on a 1-year basis, and lags it on a 5-year basis
  • The company share price beats the performance of its peers in the Health Care industry sector today, beats it on a 1-year basis, and lags it on a 5 year basis
NameDoD %ΔYTD %Δ1 Yr %52-Week H %52-Week L %
Synthetic Biologics Inc.14.464.343.8-62.9141.4
Dow Jones Industrial Average0.113.528.6-1.141.9
S&P 500 Index0.513.133.5-0.144.8
Health Care1.18.822.3-1.131.3

Peer Group Comparative Performance

  • The company's stock price performance year-to-date beats the peer average by 298.3%
  • The company's stock price performance over the past 12 months beats the peer average by 299.3%
NameMKT CAP (USD)P/EYTD %Δ1 Yr %Δ52-Week H %52-Week L %
Synthetic Biologics Inc.SYN064.343.8-62.9141.4
Peer AvgN/A22.716.211.0-9.214.6
Pfizer Inc.PFE20.110.414.5-7.528.7
Abbott LaboratoriesABT33.90.422.6-14.928.5
Merck & Co IncMRK26.7-8.7-7.1-12.75.3
Astrazeneca plc - ADRAZN38.017.512.2
Biogen IncBIIB20.366.238.5
Teva- Pharmaceutical Industries Ltd. - ADRTEVA-2.911.2-15.0-20.525.4

This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.

Was this content valuable for you?